Statin therapy for preventing cardiovascular diseases in patients treated with tacrolimus after kidney transplantation

References

• OjoAOHansonJAWolfeRALeichtmanABAgodoaLYPortFKLong-term survival in renal transplant recipients with graft functionKidney Int200057130731310620213
   PubMed Web of Science ®Google Scholar
• AakhusSDahlKWideroeTECardiovascular morbidity and risk factors in renal transplant patientsNephrol Dial Transplant199914364865410193814
   PubMed Web of Science ®Google Scholar
• KasiskeBCosioFGBetoJClinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality InitiativeAm J Transplant20044Suppl 71353
   PubMed Web of Science ®Google Scholar
• OjoAOCardiovascular complications after renal transplantation and their preventionTransplantation200682560361116969281
   PubMed Web of Science ®Google Scholar
• BadiouSCristolJPMouradGDyslipidemia following kidney transplantation: diagnosis and treatmentCurr Diab Rep20099430531119640344
   PubMed Web of Science ®Google Scholar
• DeleuzeSGarrigueVDelmasSChongGSwarczICristolJPMouradGNew onset dyslipidemia after renal transplantation: is there a difference between tacrolimus and cyclosporine?Transplant Proc20063872311231316980075
   PubMed Web of Science ®Google Scholar
• VargheseZFernandoRLTurakhiaGCalcineurin inhibitors enhance low-density lipoprotein oxidation in transplant patientsKidney Int Suppl199971S137S14010412758
   PubMed Web of Science ®Google Scholar
• BaigentCKeechAKearneyPMEfficacy and safety of cholesterol-lowering treatment: prospective meta–analysis of data from 90,056 participants in 14 randomised trials of statinsLancet200536694931267127816214597
   PubMed Web of Science ®Google Scholar
• WannerCTonelliMKidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group MembersKDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patientKidney Int20148561303130924552851
   PubMed Web of Science ®Google Scholar
• StoneNJRobinsonJGLichtensteinAH2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol20146325 Pt B2889293424239923
   PubMed Web of Science ®Google Scholar
• Blanco-ColioLMTunonJMartin-VenturaJLEgidoJAnti-inflammatory and immunomodulatory effects of statinsKidney Int2003631122312472764
   PubMed Web of Science ®Google Scholar
• HoldaasHFellstromBJardineAGEffect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trialLancet200336193742024203112814712
   PubMed Web of Science ®Google Scholar
• RaggattLJPartridgeNCHMG-CoA reductase inhibitors as immunomodulators: potential use in transplant rejectionDrugs200262152185219112381218
   PubMed Web of Science ®Google Scholar
• HoldaasHFellstromBColeELong-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension studyAm J Transplant20055122929293616303007
   PubMed Web of Science ®Google Scholar
• KobashigawaJAKatznelsonSLaksHEffect of pravastatin on outcomes after cardiac transplantationN Engl J Med1995333106216277637722
   PubMed Web of Science ®Google Scholar
• CosioFGPesaventoTEPelletierRPHenryMFergusonRMKimSLemeshowSPatient survival after renal transplantation III: the effects of statinsAm J Kidney Dis200240363864312200817
   PubMed Web of Science ®Google Scholar
• JohnsonBAIaconoATZeeviAMcCurryKRDuncanSRStatin use is associated with improved function and survival of lung allograftsAm J Resp Crit Care2003167912711278
   PubMed Web of Science ®Google Scholar
• PalmerSCNavaneethanSDCraigJCHMG CoA reductase inhibitors (statins) for kidney transplant recipientsCochrane Database Syst Rev20141CD00501924470059
   PubMed Web of Science ®Google Scholar
• MatasAJSmithJMSkeansMAOPTN/SRTR 2013 Annual Data Report: kidneyAm J Transplant201515Suppl 2134
   PubMed Web of Science ®Google Scholar
• MargreiterREuropean Tacrolimus vs Ciclosporin Microemulsion Renal Transplantation Study GroupEfficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre studyLancet2002359930874174611888584
   PubMed Web of Science ®Google Scholar
• JardineAAssessing cardiovascular risk profile of immunosuppressive agentsTransplantation20017212 SupplS81S8811833146
   PubMed Web of Science ®Google Scholar
• IchimaruNTakaharaSKokadoYChanges in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimusAtherosclerosis2001158241742311583721
   PubMed Web of Science ®Google Scholar
• AsbergAHartmannAFjeldsaEBerganSHoldaasHBilateral pharmacokinetic interaction between cyclosporine A and atorvastatin in renal transplant recipientsAm J Transplant20011438238612099384
   PubMed Web of Science ®Google Scholar
• McGowanMPTreating to New Target (TNT) Study GroupThere is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in ss cardiac patientsCirculation2004110162333233515477411
   PubMed Web of Science ®Google Scholar
• YuOEbergMBenayounSAprikianABatistGSuissaSAzoulayLUse of statins and the risk of death in patients with prostate cancerJ Clin Oncol201432151124190110
   PubMed Web of Science ®Google Scholar
• ChiuHFChangCCHoSCWuTNYangCYStatin use and the risk of pancreatic cancer: a population-based case-control studyPancreas201140566967221654539
   PubMed Web of Science ®Google Scholar
• von ElmEAltmanDGEggerMPocockSJGøtzschePCVandenbrouckeJPSTROBE InitiativeThe Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesAnn Intern Med2007147857357717938396
   PubMed Web of Science ®Google Scholar
• KipKEHollabaughKMarroquinOCWilliamsDOThe problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary interventionJ Am Coll Cardiol200851770170718279733
   PubMed Web of Science ®Google Scholar
• Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative GroupArmitageJBowmanLIntensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trialLancet201037697531658166921067805
   PubMed Web of Science ®Google Scholar
• Lloyd-JonesDAdamsRCarnethonMHeart disease and stroke statistics – 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics SubcommitteeCirculation20091193e21e18119075105
   PubMed Web of Science ®Google Scholar
• PrasadGVHuangMSilverSAAl-LawatiAIRapiLNashMMZaltzmanJSMetabolic syndrome definitions and components in predicting major adverse cardiovascular events after kidney transplantationTranspl Int2015281798825207680
   PubMed Web of Science ®Google Scholar
• TaylorFHuffmanMDMacedoAFStatins for the primary prevention of cardiovascular diseaseCochrane Database Syst Rev20131CD00481623440795
   PubMed Web of Science ®Google Scholar
• SchachingerVBrittenMBZeiherAMPrognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart diseaseCirculation2000101161899190610779454
   PubMed Web of Science ®Google Scholar
• AndersonTJMeredithITYeungACFreiBSelwynAPGanzPThe effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotionN Engl J Med199533284884937830729
   PubMed Web of Science ®Google Scholar
• AlbertMADanielsonERifaiNRidkerPMPRINCE InvestigatorsEffect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort studyJAMA20012861647011434828
   PubMed Web of Science ®Google Scholar
• HackmanAAbeYInsullWJrLevels of soluble cell adhesion molecules in patients with dyslipidemiaCirculation1996937133413388641021
   PubMed Web of Science ®Google Scholar
• CrisbyMNordin-FredrikssonGShahPKYanoJZhuJNilssonJPravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilizationCirculation2001103792693311181465
   PubMed Web of Science ®Google Scholar
• Sanchez-QuesadaJLOtal-EntraigasCFrancoMJorbaOGonzález-SastreFBlanco-VacaFOrdóñez-LlanosJEffect of simvastatin treatment on the electronegative low-density lipoprotein present in patients with heterozygous familial hypercholesterolemiaAm J Cardiol199984665565910498134
   PubMed Web of Science ®Google Scholar
• FurbergCDNatural statins and stroke riskCirculation19999921851889892578
   PubMed Web of Science ®Google Scholar
• GillJSCardiovascular disease in transplant recipients: current and future treatment strategiesClin J Am Soc Nephrol20083Suppl 2S29S3718309001
   PubMed Web of Science ®Google Scholar
• KasiskeBLUmenAJPersistent hyperlipidemia in renal transplant patientsMedicine (Baltimore)19876643093163298932
   PubMed Web of Science ®Google Scholar
• SpinelliGAFelipeCRParkSIMandia-SampaioELTedesco-SilvaHJrMedina-PestanaJOLipid profile changes during the first year after kidney transplantation: risk factors and influence of the immunosuppressive drug regimenTransplant Proc201143103730373722172836
   PubMed Web of Science ®Google Scholar
• MoralesJMMarcenRdel CastilloDRisk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multicentre studyNephrol Dial Transplant201227Suppl 4iv39iv4623258810
   PubMed Web of Science ®Google Scholar
• PedersenTRFaergemanOKasteleinJJHigh-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trialJAMA2005294192437244516287954
   PubMed Web of Science ®Google Scholar
• SilberbergJSBarrePEPrichardSSSnidermanADImpact of left ventricular hypertrophy on survival in end-stage renal diseaseKidney Int19893622862902528654
   PubMed Web of Science ®Google Scholar
• LindnerACharraBSherrardDJScribnerBHAccelerated atherosclerosis in prolonged maintenance hemodialysisN Engl J Med1974290136977014813742
   PubMed Web of Science ®Google Scholar
• IbelsLSAlfreyACHufferWECraswellPWAndersonJTWeilR3rdArterial calcification and pathology in uremic patients undergoing dialysisAm J Med1979665790796443254
   PubMed Web of Science ®Google Scholar
• HernandezDRufinoMBartolomeiSGonzález-RinneALorenzoVCoboMTorresAClinical impact of preexisting vascular calcifications on mortality after renal transplantationKidney Int20056752015202015840052
   PubMed Web of Science ®Google Scholar
• VanrenterghemYFClaesKMontagninoGFieuwsSMaesBVillaMPonticelliCRisk factors for cardiovascular events after successful renal transplantationTransplantation200885220921618212625
   PubMed Web of Science ®Google Scholar
• Meier-KriescheHUPortFKOjoAOEffect of waiting time on renal transplant outcomeKidney Int20005831311131710972695
   PubMed Web of Science ®Google Scholar
• ChawlaVGreeneTBeckGJKusekJWCollinsAJSarnakMJMenonVHyperlipidemia and long-term outcomes in nondiabetic chronic kidney diseaseClin J Am Soc Nephrol2010591582158720558558
   PubMed Web of Science ®Google Scholar
• GrundySMCleemanJIMerzCNImplications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesCirculation2004110222723915249516
   PubMed Web of Science ®Google Scholar